PMID- 31767009 OWN - NLM STAT- MEDLINE DCOM- 20200414 LR - 20200414 IS - 1472-6823 (Electronic) IS - 1472-6823 (Linking) VI - 19 IP - 1 DP - 2019 Nov 25 TI - Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies. PG - 125 LID - 10.1186/s12902-019-0453-5 [doi] LID - 125 AB - BACKGROUND: Compositional abnormalities in lipoproteins and cardiovascular risk factors play an important role in the progression of diabetic peripheral neuropathy (DPN). This systematic review aimed to estimate the predicting value of low-density lipoprotein (LDL) and systolic blood pressure (SBP) level in type-2 diabetes mellitus (T2DM) patients with and without peripheral neuropathy. We also tried to determine whether LDL and SBP are associated with an increased collision risk of DPN. METHODS: A systematic search was conducted for eligible publications which explored the LDL and SBP level in T2DM patients with and without peripheral neuropathy. The quality of the included studies was assessed by the QUADAS-2 tool. The standardized mean difference (SMD) with 95% CI of LDL and SBP level were pooled to assess the correlation between LDL and SBP level with DPN. We performed random effects meta-regression analyses to investigate factors associated with an increased collision risk of DPN. RESULTS: There was a significant association between LDL and SBP with poor prognosis of DPN in those included studies (I(2) = 88.1% and I(2) = 84.9%, respectively, Both P < 0.001). European T2DM patients have higher serum level of LDL in compare with the European DPN patients (SMD = 0.16, 95% CI: - 0.06 - 0.38; P < 0.001). SBP level was associated with a 2.6-fold decrease in non-DPN patients of T2DM (SMD = - 2.63, 95% CI: - 4.00 - -1.27, P < 0.001). Old age European T2DM patients have significantly high risk for diabetes drivers. Furthermore, the results of the case-control study design model are more precise to show the accuracy of SBP in Asian T2DM patients. CONCLUSION: Our finding supports the LDL and SBP status could be associated with increased risk of peripheral neuropathy in T2DM patients. FAU - Naqvi, Syed Shah Zaman Haider AU - Naqvi SSZH AD - Department of Diabetes and Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Imani, Saber AU - Imani S AD - Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Hosseinifard, Hossein AU - Hosseinifard H AD - Research Center for Evidence Based Medicine (RCEBM), Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Wen, Qing-Lian AU - Wen QL AD - Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Shahzad, M Naveed AU - Shahzad MN AD - Stem Cell Laboratory, Department of Hematology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Ijaz, Iqra AU - Ijaz I AD - Sichuan Provincial Center for Gynecological and Breast Diseases, Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Deng, Youcai AU - Deng Y AD - Institute of Materia Medical, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China. FAU - Guo, Man AU - Guo M AD - Luzhou Key Laboratory of Cardiovascular and Metabolic Diseases, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. FAU - Xu, Yong AU - Xu Y AD - Department of Diabetes and Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People's Republic of China. xywyll@aliyun.com. LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20191125 PL - England TA - BMC Endocr Disord JT - BMC endocrine disorders JID - 101088676 RN - 0 (Lipoproteins, LDL) SB - IM MH - *Blood Pressure MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*complications MH - Diabetic Neuropathies/blood/etiology/*physiopathology MH - Humans MH - Lipoproteins, LDL/*blood MH - Observational Studies as Topic MH - Prognosis MH - *Systole PMC - PMC6878654 OTO - NOTNLM OT - Diabetic peripheral neuropathy OT - Low-density lipoprotein OT - Meta-analysis OT - Meta-regression OT - Systolic blood pressure OT - Type 2 diabetes COIS- The authors declare that they have no competing interests. EDAT- 2019/11/27 06:00 MHDA- 2020/04/15 06:00 PMCR- 2019/11/25 CRDT- 2019/11/27 06:00 PHST- 2019/07/10 00:00 [received] PHST- 2019/10/31 00:00 [accepted] PHST- 2019/11/27 06:00 [entrez] PHST- 2019/11/27 06:00 [pubmed] PHST- 2020/04/15 06:00 [medline] PHST- 2019/11/25 00:00 [pmc-release] AID - 10.1186/s12902-019-0453-5 [pii] AID - 453 [pii] AID - 10.1186/s12902-019-0453-5 [doi] PST - epublish SO - BMC Endocr Disord. 2019 Nov 25;19(1):125. doi: 10.1186/s12902-019-0453-5.